Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more...
Hims & Hers will get to sell Ozempic. Like, real Ozempic. The stock soa
Novo Nordisk and Hims had clashed on and off for months as the telehealth firm marketed compounded versions of Novo's blockbuster GLP-1 drug Wegovy
[...]
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e52d965976c1e0c2f8d89ccb548a2577.jpg"/><p>Novo Nordisk just cut the price of i [...]